Abstract:
Background. Cholecystectomy is used in the treatment of cholelithiasis and cholecystitis,
with a global incidence of over one million cases annually. Although effective, 10–30% of
patients develop post-cholecystectomy syndrome (PCS), manifested by upper abdominal
pain, bloating, diarrhea, dyspepsia, or jaundice.
Objective(s). To identify the causes and effective therapeutic strategies in PCS, with
emphasis on risk factors and treatment outcomes in symptomatic patients with postcholecystectomy syndrome.
Materials and methods. Extensive literature research was carried out by looking through
the databases Pub Med, Web of science and Medscape. Included were studies on PCS's
clinical presentation, diagnostic techniques, and therapy
Results. To provide an overview of PCS's prevalence, common causes, diagnostic methods,
through data extraction and analysis.
Results. PCS affects 5% to 40% of patients with cholecystectomy. Sphincter Oddi
dysfunction, biliary strictures, and retained common bile duct stones are as biliary factors.
Peptic ulcer and pancreatic diseases are non-biliary factors. Endoscopic retrograde
cholangiopancreatography, magnetic resonance cholangiopancreatography and ultrasound
is recommended. Treatment options include sphincterotomy, endoscopic stone removal,
and medication management of gastrointestinal symptoms, depending on the etiology. Most
individuals have a considerable improvement in their symptoms with early diagnosis and
individualized treatment.
Conclusion(s). Post Cholecystectomy Syndrome is a rare but important complication.
Personalized treatment improves symptoms and quality of life. Multidisciplinary evaluation
is essential to distinguish biliary from non-biliary causes and to ensure appropriate
management and better patient outcomes.
